How helpful was this article to you or your practice?
- Your Rating
-
- Overall Rating
-
( reviews )
Clinical Trial Listings: Crohn
| Product Name/Compound | Unique Protocol ID | Conditions | Brief Title | Study Phase | Status |
|---|---|---|---|---|---|
| Recombinant Human Interleukin-11 (rhIL-11) | 3067K5-208 | Crohn Disease, Inflammatory Bowel Disease, | Study evaluating rhIL-11 in Active Crohn’s Disease | Phase 2 | Completed |
| ERB-041 | 3142A3-102 | Crohn's Disease, | Study evaluating ERB-041 in Active Crohn's Disease | Phase 1 | No longer recruiting |
Back to Clinical Trial Listing Page
Have a question about our clinical trials? Send an email to clintrialparticipation@wyeth.com
The content on this page summarizes current scientific and medical research being conducted by Wyeth Pharmaceuticals. The intervention used in this study is investigational and is not available commercially. The safety and efficacy of this intervention has not been determined and this intervention has not been approved by FDA. No promotional claims about the products or product indications listed here should be inferred.